Article History
Received: 30 January 2021
Accepted: 20 July 2021
First Online: 30 July 2021
Declarations
:
: Federico Lavorini reports personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, HIKMA, Menarini International, Novartis, Orion, TEVA, Trudell International, research grants from AstraZeneca and GlaxoSmithKline, all of which are outside the submitted work. Omar S. Usmani reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi and GlaxoSmithKline, personal fees from Aerocrine, Cipla, Covis, DEVA, Napp, Menarini, Mundipharma, Orion, Sandoz, Takeda, Trudell International, Zentiva, and grants from Edmond Pharma, all of which are outside the submitted work. Rajiv Dhand reports personal fees from Astra-Zeneca, Boehringer-Ingelheim, Mylan, UptoDate, Teva, and research grant form Mylan, all of which are outside the submitted work.
: This manuscript is a point of view article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.
: For this type of study, formal consent is not required.
Free to read: This content has been made available to all.